Impact of Diabetes on Cardiac Function in Patients with High Blood Pressure
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Background: Although the combination of high blood pressure (HBP) and type 2 diabetes (T2DM) increases the risk of left ventricular (LV) dysfunction, the impact of T2DM on LV geometry and subclinical dysfunction in hypertensive patients and normal ejection fraction (EF) has been infrequently evaluated. Methods: Hypertensive patients with or without T2DM underwent cardiac echocardiography coupled with LV global longitudinal strain (GLS) assessment. Results: Among 200 patients with HBP (mean age 61.7 ± 9.7 years) and EF > 55%, 93 had associated T2DM. Patients with T2DM had a higher body mass index (29.9 ± 5.1 kg/m2 vs. 29.3 ± 4.7 kg/m2, p = 0.025), higher BP levels (158 ± 23/95 ± 13 vs. 142 ± 33/87 ± 12 mmHg, p = 0.003), a higher LV mass index (115.8 ± 32.4 vs. 112.0 ± 24.7 g/m2, p = 0.004), and higher relative wall thickness (0.51 ± 0.16 vs. 0.46 ± 0.12, p = 0.0001). They had more frequently concentric remodeling (20.4% vs. 16.8%, p < 0.001), concentric hypertrophy (53.7% vs. 48.6%, p < 0.001), elevated filling pressures (25.8 vs. 12.1%, p = 0.0001), indexed left atrial volumes greater than 28 mL/m2 (17.2 vs. 11.2%, p = 0.001), and a reduced GLS less than −18% (74.2 vs. 47.7%, p < 0.0001). After adjustment for BP and BMI, T2DM remains an independent determinant factor for GLS decline (OR = 2.26, 95% CI 1.11–4.61, p = 0.023). Conclusions: Left ventricular geometry and subclinical LV function as assessed with GLS are more impaired in hypertensive patients with than without T2DM. Preventive approaches to control BMI and risk of T2DM in hypertensive patients should be emphasized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“ACE inhibitors and ARBs should not be used together and should be used with caution with spironolactone to avoid hyperkalemia or AKI.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [258]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318 · cited 1×
“Records connected to an ECG were obtained from 3 consecutive cardiac cycles at each plane at end-expiration breath, as recommended by the American Society of Echocardiography [12].”
MethodMancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,824
Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms
Petrie, J. R., Guzik, T. J., & Touyz, R. M. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.12.005 · Cited by 1,787 · cited 1×
“antihypertensive drugs such as angiotensin-converting enzyme inhibitors, as observed in the present study, may have direct protective effects, and their use may contribute to reduced vascular complications in patients with HBP and concomitant T2DM [25].”
BackgroundRapsomaniki, E., Timmis, A., George, J., Pujades-Rodriguez, M., Shah, A. D., Denaxas, S., White, I. R., Caulfield, M. J., Deanfield, J. E., Smeeth, L., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60685-1 · Cited by 1,643
Leitman, M., Lysyansky, P., Sidenko, S., Shir, V., Peleg, E., Binenbaum, M., Kaluski, E., Krakover, R., & Vered, Z. (2004) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2004.06.019 · Cited by 1,187 · cited 2×
“Although two-dimensional echocardiography (2-DE) may track changes in LV diastolic and systolic function, assessment of LV global longitudinal strain (GLS) by speckletracking provides recognition of LV impairment and its associated factors at an earlier stage [9].”
BackgroundMethodDiabetes and hypertension: the bad companions
Ferrannini, E., & Cushman, W. C. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60987-8 · Cited by 695 · cited 2×
“Introduction The colluding effects of the two most common noncommunicable diseases, hypertension and type 2 diabetes mellitus (T2DM), result in a severalfold elevation in risk for cardiovascular morbidity and mortality [1].”
BackgroundImbalzano, E., Zito, C., Carerj, S., Oreto, G., Mandraffino, G., Cusmà-Piccione, M., Di Bella, G., Saitta, C., & Saitta, A. (2011) · Echocardiography · doi:10.1111/j.1540-8175.2011.01410.x · Cited by 154
Development of heart failure in recent hypertension trials
Tocci, G., Sciarretta, S., & Volpe, M. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282fe1d3d · Cited by 131 · cited 1×
“The association of HBP and T2DM further increases the risk of progressive LV dysfunction and heart failure [6].”
BackgroundKosmala, W., Plaksej, R., Strotmann, J. M., Weigel, C., Herrmann, S., Niemann, M., Mende, H., Störk, S., Angermann, C. E., Wagner, J. A., et al. (2008) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2008.10.006 · Cited by 120
Muranaka, A., Yuda, S., Tsuchihashi, K., Hashimoto, A., Nakata, T., Miura, T., Tsuzuki, M., Wakabayashi, C., Watanabe, N., & Shimamoto, K. (2009) · Echocardiography · doi:10.1111/j.1540-8175.2008.00805.x · Cited by 115
Diabetic heart disease: A clinical update
Rajbhandari, J., Fernandez, C. J., Agarwal, M., Yeap, B. X. Y., & Pappachan, J. M. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i4.383 · Cited by 102 · cited 1×
“Optimal control of glycemia and control of cardiovascular risk factors, especially HBP, are associated with a decrease in all-cause mortality and cardiovascular mortality [22].”
BackgroundHypertension as a Risk Factor for Heart Failure
Kannan, A., & Janardhanan, R. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0447-7 · Cited by 90 · cited 3×
“Although effective control of HBP allows most patients to remain asymptomatic for many years, LV hypertrophy, diastolic dysfunction, and heart failure may develop overtime, suggesting that early recognition of subclinical cardiac damage may be useful [2,3].”
BackgroundSoufi Taleb Bendiab, N., Meziane-Tani, A., Ouabdesselam, S., Methia, N., Latreche, S., Henaoui, L., Monsuez, J.-J., & Benkhedda, S. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317721644 · Cited by 74 · cited 2×
“In addition, GLS is more reduced in patients with long-lasting HBP, overweight, metabolic changes, and diabetes [16].”
BackgroundSelf-citationSubendocardial Systolic Dysfunction in Asymptomatic Normotensive Diabetic Patients
Enomoto, M., Ishizu, T., Seo, Y., Yamamoto, M., Suzuki, H., Shimano, H., Kawakami, Y., & Aonuma, K. (2015) · Circulation Journal · doi:10.1253/circj.cj-15-0012 · Cited by 67
Wagner, M., Tiffe, T., Morbach, C., Gelbrich, G., Störk, S., & Heuschmann, P. U. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316680693 · Cited by 57 · cited 1×
“Although effective control of HBP allows most patients to remain asymptomatic for many years, LV hypertrophy, diastolic dysfunction, and heart failure may develop overtime, suggesting that early recognition of subclinical cardiac damage may be useful [2,3].”
BackgroundShah, R. V., Murthy, V. L., Abbasi, S. A., Eng, J., Wu, C., Ouyang, P., Kwong, R. Y., Goldfine, A., Bluemke, D. A., Lima, J., et al. (2015) · European Journal of Preventive Cardiology · doi:10.1177/2047487314541731 · Cited by 42 · cited 1×
“Indeed, weight loss has been reported to improve cardiac structure and function of patients with overweight [23].”
BackgroundTadić, M., Cuspidi, C., Vukomanovic, V., Ilic, S., Obert, P., Kocijancic, V., & Celic, V. P. (2017) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2017.01.014 · Cited by 38 · cited 5×
“Cardiac Geometry M-mode derived measurements of end-diastolic LV diameter (Dd), end-systolic LV diameter (Ds), end-diastolic thickness of the ventricular septum (VST), and end-diastolic thickness of the LV posterior wall (PWT) allowed calculation of LV mass and relative LV wall thickness (RWT) as follows: - LV mass (g…”
MethodInfluentialLi, X., Jiang, L., Guo, Y., Ren, Y., Han, P., Peng, L., Shi, R., Yan, W., & Yang, Z. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01138-w · Cited by 34 · cited 2×
“Abnormalities of the microvascular perfusion may compromise nutrients and oxygen delivery, energy production, and, in turn, myocardial contractility [21].”
BackgroundMethodAyoub, A., Keddeas, V. W., Ali, Y. A., & Okl, R. A. E. (2016) · Clinical Medicine Insights Cardiology · doi:10.4137/cmc.s38407 · Cited by 30
Wang, Q., Gao, Y., Tan, K., Xia, H., & Li, P. (2015) · Journal of Clinical Ultrasound · doi:10.1002/jcu.22268 · Cited by 29 · cited 1×
“On the other hand, early impairment of GLS is observed in patients with T2DM [5,17], which is worsened by coexistent hypertension [18–20].”
BackgroundFerrini, M., Johansson, I., & Aboyans, V. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319885461 · Cited by 21 · cited 3×
“Direct effects of insulin resistance/hyperglycemia on the myocardium may contribute to a condition generally referred to as diabetic cardiomyopathy, including mitochondrial dysfunction, endoplasmic reticulum stress, oxidative stress, production of advanced glycosylation end products, impaired calcium homeostasis, reni…”
BackgroundStevanovic, A., & Dekleva, M. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.07.022 · Cited by 14
Mannina, C. M., Jin, Z., Russo, C. A., Homma, S., Elkind, M. S. V., Rundek, T., Lee, T. C., Matsumoto, K., Shames, S., Sacco, R. L., et al. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319872571 · Cited by 12 · cited 1×
“Although previous studies have observed more severe subclinical systolic dysfunction in patients with coexisting T2DM and hypertension than in patients with T2DM only [7,8], none have evaluated the impact of T2DM on LV geometry and LV subclinical dysfunction in patients with hypertension.”
The Impact of Uncontrolled Hypertension on the Longitudinal Systolic Function of the Left Ventricle
Bendiab, N. T., Benkhedda, S., Henaoui, L., & Tani, A. M. (2021) · Current Hypertension Reviews · doi:10.2174/1573402117666210218105338 · Cited by 4 · cited 1×
“Accordingly, effective and optimal treatment of HBP should be obtained in very high risk hypertensive patients such as those with T2DM [24].”
BackgroundSelf-citation
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Li, Z., Han, D., Qi, T., Deng, J., Li, L., Gao, C., Gao, W. D., Chen, H., Zhang, L., & Chen, W. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03082-5 · Cited by 15
“023) [36], which is consistent with the findings of our study.”
ResultRole of Strain in the Early Diagnosis of Diabetic Cardiomyopathy
da Silva, T. R. W., da Silva, R. L., Martins, A. F., & Marques, J. L. B. (2022) · ARQUIVOS BRASILEIROS DE CARDIOLOGIA - IMAGEM CARDIOVASCULAR · doi:10.47593/2675-312x/20223502eabc293 · Cited by 7
Noori, A. A., & Barzani, M. A. (2022) · The Open Cardiovascular Medicine Journal · doi:10.2174/18741924-v16-e221202-2022-8 · Cited by 6
Anan, R., Imoto, T., Onizuka, K., Watanabe, H., Mori, W., & Murakoso, M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16252 · Cited by 6
Metadata
- Authors
- Soufi Taleb Bendiab, N., Ouabdesselam, S., Henaoui, L., Lopez-Sublet, M., Monsuez, J.-J., & Benkhedda, S.
- Affiliations
- Department of Cardiology, Faculty of Medicine Aboubekr Belkaid, University Hospital Tlemcen, Tlemcen 13000, Algeria
- University of Algiers Benyoucef Benkhedda (DZ)
- University of Abou Bekr Belkaïd (DZ)
- APHP Hôpital R Muret, Hôpitaux Universitaires de Paris Seine Saint Denis, 93270 Sevran, France
- Hôpital René-Muret (FR)
- Corresponding author
- Monsuez, Jean-Jacques
- Venue
- International Journal of Environmental Research and Public Health
- Publisher
- MDPI AG
- Published
- 2021-06-18
- Volume
- 18
- Issue
- 12
- Pages
- 6553
- ISSN
- 1660-4601 (ISSN-L)
- PMC
- PMC8296398
- OpenAlex
- W3171300389
- Cited by
- 9
- References
- 25
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 2
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Environmental Research and Public Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- type 2 diabetes, hypertension, left ventricular function, global longitudinal strain, left ventricular geometry, subclinical systolic dysfunction, concentric hypertrophy, left ventricular mass, left atrial volume, filling pressure, normal ejection fraction, body mass index, echocardiography, cardiac magnetic resonance imaging
- MeSH terms
- Aged, Blood Pressure, Diabetes Mellitus, Type 2, Echocardiography, Humans, Hypertension, Middle Aged, Stroke Volume, Ventricular Function, Left, Ventricular Dysfunction, Left
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.